1Life Healthcare (ONEM) Stock Forecast, Price & News

12 Wall Street analysts have issued "buy," "hold," and "sell" ratings for 1Life Healthcare in the last year. There are currently 12 hold ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" ONEM shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in ONEM, but not buy additional shares or sell existing shares.
View ONEM analyst ratings or view top-rated stocks.

12 Wall Street research analysts have issued 1-year price targets for 1Life Healthcare's stock. Their ONEM share price forecasts range from $15.00 to $18.00. On average, they predict the company's share price to reach $17.70 in the next twelve months. This suggests a possible upside of 7.5% from the stock's current price.
View analysts price targets for ONEM or view top-rated stocks among Wall Street analysts.

1Life Healthcare, Inc. (NASDAQ:ONEM) posted its earnings results on Tuesday, February, 21st. The company reported ($0.49) EPS for the quarter, topping the consensus estimate of ($0.52) by $0.03. The company had revenue of $274.24 million for the quarter, compared to the consensus estimate of $276.10 million. 1Life Healthcare had a negative net margin of 38.05% and a negative trailing twelve-month return on equity of 24.58%. 1Life Healthcare's quarterly revenue was up 19.1% on a year-over-year basis. During the same quarter in the previous year, the company posted ($0.50) EPS.

98 employees have rated 1Life Healthcare Chief Executive Officer Amir Dan Rubin on Glassdoor.com. Amir Dan Rubin has an approval rating of 71% among the company's employees.

Based on aggregate information from My MarketBeat watchlists, some companies that other 1Life Healthcare investors own include Teladoc Health (TDOC), Advanced Micro Devices (AMD), Fastly (FSLY), Etsy (ETSY), Livongo Health (LVGO), NVIDIA (NVDA), Boeing (BA), Alibaba Group (BABA), Walt Disney (DIS) and DocuSign (DOCU).

(ONEM) raised $262 million in an initial public offering (IPO) on Friday, January 31st 2020. The company issued 17,500,000 shares at a price of $14.00-$16.00 per share. J.P. Morgan and Morgan Stanley served as the underwriters for the IPO and Allen & Company LLC, Citigroup, Piper Jaffray, Wells Fargo Securities, William Blair, Baird and SunTrust Robinson Humphrey were co-managers.

1Life Healthcare trades on the NASDAQ under the ticker symbol "ONEM."

1Life Healthcare's stock is owned by many different institutional and retail investors. Top institutional shareholders include Group One Trading L.P. (0.00%), Clear Street Markets LLC (0.00%), Wolverine Asset Management LLC (0.00%), Cutler Group LLC CA (0.00%), Equitec Proprietary Markets LLC (0.00%) and Simplex Trading LLC (0.00%). Insiders that own company stock include Amir Dan Rubin, Andrew S Diamond, Bjorn B Thaler, Bjorn B Thaler, David P Kennedy, Holmes Kalen, Kimber D Lockhart, Kimber D Lockhart, Lisa A Mango, Lisa A Mango and Vikas Agarwal.
View institutional ownership trends.

One share of ONEM stock can currently be purchased for approximately $16.47.

1Life Healthcare (NASDAQ:ONEM) has a market capitalization of $3.37 billion and generates $1.05 billion in revenue each year. The company earns $-254,640,000.00 in net income (profit) each year or ($2.01) on an earnings per share basis.

The company employs 3,090 workers across the globe.

1Life Healthcare's mailing address is One Embarcadero Center Suite 1900, San Francisco CA, 94111. The official website for the company is www.onemedical.com. The company can be reached via phone at 415-814-0927 or via email at investor@onemedical.com.